Creative Price To Book Ratio from 2010 to 2024

CELZ Stock  USD 2.19  0.12  5.19%   
Creative Medical Price To Book Ratio yearly trend continues to be fairly stable with very little volatility. Price To Book Ratio is likely to outpace its year average in 2024. Price To Book Ratio is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share. View All Fundamentals
 
Price To Book Ratio  
First Reported
2010-12-31
Previous Quarter
0.6273503
Current Value
0.66
Quarterly Volatility
87.66604363
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.2 M, Other Operating Expenses of 5.9 M or Total Operating Expenses of 5.8 M, as well as many indicators such as Price To Sales Ratio of 757, Dividend Yield of 0.0039 or PTB Ratio of 0.66. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Price To Book Ratio Growth Pattern

Below is the plot of the Price To Book Ratio of Creative Medical Technology over the last few years. It is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share. Creative Medical's Price To Book Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Price To Book Ratio10 Years Trend
Very volatile
   Price To Book Ratio   
       Timeline  

Creative Price To Book Ratio Regression Statistics

Arithmetic Mean(22.65)
Geometric Mean1.29
Coefficient Of Variation(387.11)
Mean Deviation42.23
Median(0.69)
Standard Deviation87.67
Sample Variance7,685
Range349
R-Value0.06
Mean Square Error8,248
R-Squared0
Significance0.84
Slope1.15
Total Sum of Squares107,595

Creative Price To Book Ratio History

2024 0.66
2023 0.63
2022 0.26
2021 0.56
2020 -0.2
2019 -0.0577
2018 -2.24

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Price To Book Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Book Ratio 0.63  0.66 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.